Propagation of population pharmacokinetic information using a Bayesian approach: Comparison with meta-analysis

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 32, Issue 3-4, 2005, Pages 401-418

  Dokoumetzidis, Aristides ^a   Aarons, Leon ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bayesian analysis; Meta analysis; Nonlinear mixed effect modeling; Population pharmacokinetics; Priors; WinBUGS

Indexed keywords

DOFETILIDE; MIDAZOLAM;

ARTICLE; BAYES THEOREM; COMPUTER PROGRAM; DATA ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEDICAL INFORMATION SYSTEM; NONHUMAN; PARAMETER; POPULATION DYNAMICS; PRIORITY JOURNAL; SIMULATION; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ANIMALS; BAYES THEOREM; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; HUMANS; INJECTIONS, INTRAVENOUS; META-ANALYSIS; MIDAZOLAM; MODELS, BIOLOGICAL; PHENETHYLAMINES; RATS; SULFONAMIDES;

EID: 28444488920     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10928-005-0048-9     Document Type: Article

References (18)

1. A. Gelman JB. Carlin HS. Stern D.B. Rubin 1995 Bayesian Data Analysis Chapman & Hall London
2. A. Racine-Poon 1985 A Bayesian approach to nonlinear random effects models Biometrics 41 1015 1023
3. A. Gelman F. Bois J. Jiang 1996 Physiological pharmacokinetic analysis using population modeling and informative prior distribution J. Am. Stat. Assoc. 91 1400 1412
4. Gamerman D., Smith A.F.M. (1996). Bayesian analysis of longitudinal data studies. In Bayesian Statistics 5, J. M Bernardo, Berger JO., A. P. Dawid and A. F. M. Smith, (eds), Oxford: University Press, Oxford, 1996, pp. 587-597
5. J. Wakefield 1996 The Bayesian analysis of population pharmacokinetic models J. Am. Stat. Assoc. 91 62 75
6. D.J. Lunn L.J. Aarons 1997 Markov Chain Monte Carlo techniques for studying interoccasion and intersubject variability: Application to pharmacokinetics data Appl Statist. 46 73 91
7. JE. Bennett JC. Wakefield L.F. Lacey 1997 Modeling of trough plasma bismuth concentrations J. Pharmacokinet Biopharm. 25 79 106
8. J. Wakefield N. Rahman 2000 The combination of population pharmacokinetics studies Biometrics 56 263 270
9. H. Putter SH. Heisterkamp J.M.A. Lange F. de Solf 2002 A Bayesian approach to parameter estimation in HIV dynamical models Stat. Med. 21 2199 2214
10. G. Graham S. Gupta L. Aarons 2002 Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data J. Pharmacokinet. Pharmacodyn. 29 67 88
11. WR. Gilds S. Richardson D.J. Spiegelhalter 1995 Markov Chain Monte Carlo in practice Chapman & Hall London
12. DJ. Lunn N. Best A. Thomas J. Wakefield D Spiegelhalter 2002 Bayesian analysis of population PK/PD models: general concepts and software J. Pharmacokinet Pharmacodyn. 29 271 307
13. S. Mu T.M. Ludden 2003 Estimation of population pharmacokinetic parameters in the presence of non-compliance J. Pharmacokinet. Pharmacodyn. 30 53 81
14. I.S. Nam. Propagation of information in pharmacokinetic and pharmacodynamic studies during drug development. PhD Thesis. Unversity of Manchester, Manchester, 2003
15. L. Aarons JW. Mandema M. Danhof 1991 A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat J. Pharmacokinet. Biopharm. 19 485 496
16. JW. Mandema E. Tukker M. Danhof 1992 In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil J Pharmacol. Exp. Ther. 260 36 44
17. RJ. Muirhead 1982 Aspects of multivariate statistical theory Wiley New York
18. J. Wakefield N. Rahman 2000 The combination of population pharmacokinetics studies Biometrics 56 263 270